A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation. [PDF]
Arch Endocrinol Metab, 2021 Reis FS +3 more
europepmc +1 more source
Perinatal hypophosphatasia refractory to asfotase alfa with neutralizing antibodies that affected bone mineralization: a case report. [PDF]
Clin Pediatr EndocrinolKamoda Y +7 more
europepmc +1 more source
Successful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia. [PDF]
Osteoporos IntWindels O +4 more
europepmc +1 more source
Alfa-Cakes-Fabrik, Radebul-Dresden
ALFA-CAKES-FABRIK, RADEBUL-DRESDEN Alfa-Cakes-Fabrik, Radebul-Dresden ( -
Alfa-Cakes-Fabrik
core +1 more source
Effects of comorbid chronic kidney disease on late-onset hypophosphatasia mice under treatment with asfotase alfa. [PDF]
JBMR PlusTokuhara C +5 more
europepmc +1 more source
Adult Hypophosphatasia in a Middle-Aged Patient With Recurrent Fractures: Prevention of New Fractures With Asfotase Alfa. [PDF]
JCEM Case RepInoue R +5 more
europepmc +1 more source
Medical Management of Hypophosphatasia: Review of Data on Asfotase Alfa. [PDF]
Curr Osteoporos RepDahir KM, Dunbar NS.
europepmc +1 more source
Iatrogenic Pan-Craniosynostosis Due to Alkaline Phosphatase Enzyme Replacement Therapy Using Asfotase Alfa for Hypophosphatasia. [PDF]
J Plast Reconstr SurgKyutoku S.
europepmc +1 more source
Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia. [PDF]
Ital J Pediatrd'Angelo DM +10 more
europepmc +1 more source
Velmanasa alfa en el tratamiento de la alfa-manosidosis: eficacia y seguridad
, 2018 Se evalúa la eficacia y seguridad de velmanasa alfa en el tratamiento de la alfa-manosidosis a través de una revisión rápida que sirve de apoyo para el posicionamiento terapéutico.
Acosta García, Héctor
core